Merck & Co Inc (NYSE:MRK)
83.09 BATS BZX Real-Time Price As of 11:19am ET | ![]() Today’s Change | 65.25 Today|||52-Week Range 90.97 | +1.58% Year-to-Date |
Latest MRK News | Press Releases
Why Gilead Sciences Stock Is Jumping Today Jan 19 / MotleyFool.com - Paid Partner Content | Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals Jan 15 / Zacks.com - Paid Partner Content |
Biohaven (BHVN) Falls as Troriluzole Fails in Alzheimer's Study Jan 19 / Zacks.com - Paid Partner Content | Merck (MRK) Stock Moves -0.21%: What You Should Know Jan 14 / Zacks.com - Paid Partner Content |
AstraZeneca's (AZN) Enhertu Gets FDA Nod for Gastric Cancer Jan 19 / Zacks.com - Paid Partner Content | Esperion (ESPR) Reports Q4 Preliminary Results, Stock Down Jan 14 / Zacks.com - Paid Partner Content |
AstraZeneca (AZN) Gets EU Nod for Improved Imfinzi Dosing Jan 18 / Zacks.com - Paid Partner Content | Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA Jan 13 / Zacks.com - Paid Partner Content |
Pfizer's (PFE) Xalkori Gets FDA Nod for Rare Lymphoma in Kids Jan 15 / Zacks.com - Paid Partner Content | 3 Coronavirus Stocks to Stay Miles Away From in 2021 Jan 12 / MotleyFool.com - Paid Partner Content |
Today’s Trading
Previous close | 83.19 |
Today’s open | 83.48 |
Day’s range | 82.78 - 83.56 |
Volume | 1,627,143 |
Average volume (3 months) | 8,702,310 |
Market cap | $211.0B |
Data as of 11:19am ET, 01/20/2021
Growth & Valuation
Earnings growth (last year) | +64.36% |
Earnings growth (this year) | +15.73% |
Earnings growth (next 5 years) | +8.80% |
Revenue growth (last year) | +9.75% |
P/E ratio | 18.4 |
Price/Sales | 5.04 |
Price/Book | 8.17 |
Competitors
Today’s change | Today’s % change | |
---|---|---|
PFEPfizer | -0.15 | -0.41% |
NVSNovartis | -0.01 | -0.01% |
ABBVAbbVie | +0.37 | +0.33% |
LLYEli Lilly and Co | +1.56 | +0.79% |
Data as of 11:19am ET, 01/20/2021
Financials
Last reporting date | -- |
EPS forecast (this quarter) | $1.38 |
Annual revenue (last year) | $46.6B |
Annual profit (last year) | $9.8B |
Net profit margin | 21.13% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
